メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
Keio University ホーム
ヘルプ＆FAQ
English
日本語
ホーム
プロファイル
研究部門
研究成果
専門知識、名前、または所属機関で検索
Scopus著者プロファイル
森 英毅
内科学(消化器)
ウェブサイト
https://k-ris.keio.ac.jp/html/100003031_ja.html
h-index
1048
被引用数
19
h 指数
Pureの文献数とScopusの被引用数に基づいて算出されます
2013
2024
年別の研究成果
概要
フィンガープリント
ネットワーク
研究成果
(69)
類似のプロファイル
(6)
フィンガープリント
Hideki Moriが活動している研究トピックを掘り下げます。このトピックラベルは、この研究者の研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Medicine and Dentistry
Helicobacter Pylori
75%
Colonoscopy
52%
Bleeding
52%
Pylorus
46%
Dyspepsia
40%
Helicobacter Infection
35%
Stomach Paresis
34%
Vonoprazan
34%
Drug Therapy
30%
Randomized Controlled Trial
29%
Stomach Cancer
28%
Eradication Therapy
27%
Sitafloxacin
27%
Upper Gastrointestinal Bleeding
27%
Rescue Therapy
25%
Muscle Spasm
23%
Gastric Ulcer Bleeding
23%
COVID-19
23%
Observational Study
23%
Lidocaine
23%
Potassium Competitive Acid Blocker
20%
Infection
20%
Disease
20%
Quinolone Derivative
16%
Endoscopic Hemostasis
15%
Breathing
15%
Stomach Emptying
15%
Amoxicillin
14%
Antithrombotic
14%
Jejunum Ulcer
14%
Retrospective Study
14%
Symptom
14%
Adverse Event
13%
Gastroesophageal Reflux
13%
Quinolone
12%
Health Care Cost
12%
Apolipoprotein E
11%
Conscious Sedation
11%
Activities of Daily Living
11%
Volunteer
11%
Pethidine
11%
Gastrointestinal Disease
11%
Esophagus Ulcer
11%
Upper Digestive Tract
11%
Bile Acid Metabolism
11%
Narrow Band Imaging
11%
Air Purifier
11%
High Resolution Manometry
11%
Embolization
11%
Cryoablation
11%
Pharmacology, Toxicology and Pharmaceutical Science
Helicobacter Pylori
100%
Dyspepsia
46%
Vonoprazan
41%
Helicobacter Infection
40%
Sitafloxacin
38%
Stomach Cancer
35%
Stomach Paresis
34%
Gastritis
30%
Randomized Controlled Trial
29%
Disease
28%
Rifabutin
27%
Potassium Competitive Acid Blocker
25%
Amoxicillin
25%
Lidocaine
23%
Muscle Spasm
23%
Gastroesophageal Reflux
20%
Infection
18%
Quinolone Derivative
17%
Proton Pump Inhibitor
17%
Adverse Event
16%
Anticoagulant Agent
16%
Non-Steroidal Anti-Inflammatory Drug
14%
Symptom
13%
Retrospective Study
13%
Quinolone
12%
Bleeding
12%
Carbon 13
12%
Minimum Inhibitory Concentration
12%
Clinical Study
11%
Normal Human
11%
Pethidine
11%
Pathophysiology
11%
Apolipoprotein E Knockout Mouse
11%
Antioxidant
11%
Ghrelin
11%
Adenoma
11%
Gastric Ulcer Bleeding
11%
Magnesium Oxide
11%
Fluorouracil
11%
Adenocarcinoma
11%
Gastrointestinal Disease
11%
Midazolam
11%
CD44v Antigen
11%
Ulcer Healing
11%
Wound
11%
Apolipoprotein E
11%
Nordihydroguaiaretic Acid
11%
Epithelium Tumor
11%
Caraway
11%
Metronidazole
10%
Keyphrases
Helicobacter Pylori Eradication
61%
Eradication Therapy
28%
Gastric Cancer
25%
Risk Factors
25%
Eradication Rate
24%
Gastric Ulcer
23%
Metropolitan Areas
23%
Gastric Emptying
23%
Vonoprazan
23%
Helicobacter Pylori (H. pylori)
21%
Japan
20%
Amoxicillin
18%
Helicobacter Pylori Infection
17%
Bleeding
17%
Delayed Bleeding
15%
Endoscopic Hemostasis
14%
Delayed Gastric Emptying
14%
Rescue Therapy
14%
Colonoscopy
13%
Length of Hospital Stay
13%
Potassium-competitive Acid Blocker
11%
Non-variceal Upper Gastrointestinal Bleeding
11%
Test-and-treat
11%
Helicobacter Pylori Gastritis
11%
Double-blind Randomized Controlled Trial
11%
Multicenter Retrospective Study
11%
Activities of Daily Living
11%
Meperidine
11%
Conscious Sedation
11%
Antibiotic Resistance mutations
11%
Rifabutin
11%
7-day Triple Therapy
11%
Esophageal Ulcer
11%
Complete Closure
11%
Healthy Volunteers
11%
Inhibitory Effect
11%
Gender Differences
11%
Colonic Diverticular Bleeding
11%
Health Care Costs
11%
Aerosol Generation
11%
Air Purifier
11%
Oral Anticoagulants
11%
Mucosal Expression
11%
Plasma Ghrelin
11%
Gastric ESD
11%
Ghrelin Level
11%
CD44 Variant 9
11%
Early Detection
11%
Oral Iron Therapy
11%
Pseudomelanosis Duodeni
11%
